iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Piramal Pharma to invest Rs1,200 in UK over the next 12 to 18 months

25 Oct 2022 , 03:20 PM

Through a combination of organic growth and acquisitions in the sectors of contract development & manufacturing services (CDMO) and complicated generics, Piramal Pharma stated that it would concentrate on scaling up its operations and increasing its margins.

On October 19, its shares were listed on stock exchanges. In a recent interview with ET, Piramal Pharma chair Nandini Piramal stated that the business would invest Rs1,200 crore in antibody-drug conjugate capacity at Grangemouth, the UK, over the course of the following 12 to 18 months.

In addition to increasing capacity at its API facilities in India and for potent injectables at Lexington in the US, it is also looking to increase capacity at Riverview in the US for active pharmaceutical ingredients.

Despite immediate difficulties including fluctuating exchange rates, inflation, and energy prices, she claimed that there was still a high demand for CDMO services. Piramal claimed that the third sector, consumer health, was currently focusing on organic growth.

In October 2020, US private equity firm Carlyle Group invested $360 million in Piramal Pharma in exchange for a 20% stake. Piramal Pharma includes Piramal Pharma Solutions (PPS), a contract development and manufacturing company that generates three-fifths of its income. Piramal Critical Care (PCC), a sophisticated hospital generics company, generates 30% of the company’s revenue, with the remaining 80% coming from the over-the-counter drug market in India.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • investment
  • Piramal Pharma
  • UK
sidebar mobile


Read More
Knowledge Centerplus

Logo IIFL Customer Care Number
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

Knowledge Centerplus

Follow us on


2024, IIFL Securities Ltd. All Rights Reserved

  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.